Join the club for FREE to access the whole archive and other member benefits.

Sebastien Thuault

Chief Editor of Nature Aging

Sebastien is the launch editor of Nature Aging. Originally from France, he obtained his PhD from the University of Bristol in the United Kingdom and performed postdoctoral research in neuroscience at Columbia University in New York City. He joined Nature Research in 2011 and served as a Senior Editor at Nature Neuroscience until 2019, when he transitioned to Nature Communications to steer the Neuroscience and Psychology team. In 2018, he worked as a Publishing Manager focusing on the proposal to launch Nature Aging and took over direction of the journal in March 2020. Sebastien’s keen interest in aging originally stemmed from his years of editorial work with neuroscientists studying neurodegenerative disorders, stroke and brain aging. Since joining Nature Aging, he has expanded his knowledge and interests to many other areas of aging research.

Visit website: https://www.nature.com/nataging/about/editors

 sebastien-thuault-bab8b510

See also: Journal Nature Aging - Journal spanning the entire spectrum of research into aging

Details last updated 19-May-2020

Mentioned in this Resource

Columbia University

Private Ivy League research university in New York City

University of Bristol

Leading UK university researching infection, human rights, climate change, and information security

Sebastien Thuault News

Maximon announces 50,000 CHF (approx. £40K) Longevity Prize for Translational Research

Maximon - 01-Mar-2022

And by longevity it means "substantially increase health span or life span" - apply now!

Read more...

Nature to launch new journal dedicated to the broad spectrum of aging research

Nature - 21-Apr-2020

Anti-aging research is becoming main stream, because NOBODY is researching how to speed it up!

Read more...

Articles written by Sebastien Thuault

Interview with National Institute on Aging Scientific Director

Nature Aging - 14-Jan-2021

Most hallmarks of aging only described in mice, so far, but Luigi Ferrucci is still optimistic

Read more...